NASDAQ
Fresh Tracks Therapeutics, Inc. (FRTX) has a free cash flow growth of -136.47% as of Friday, May 29, 2026. This represents a 284.90% decrease compared to its 12-month average of 73.81%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.